The global Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |